These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 13261532)

  • 21. [Psychiatric use of serpasil].
    MELLGREN A
    Sven Lakartidn; 1956 Jun; 53(24):1564-75. PubMed ID: 13352242
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical research on chlorpromazine and reserpine in state and private psychiatric hospitals; a comparative review of the clinical problems.
    DONNELLY J; ZELLER W
    J Clin Exp Psychopathol; 1956; 17(2):180-8. PubMed ID: 13345881
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapeutic results of serpasil in 158 mental patients].
    DONINI FM; BELSASSO M; RAVIS E
    Arch Psicol Neurol Psichiatr; 1956; 17(2-3):394-8. PubMed ID: 13341406
    [No Abstract]   [Full Text] [Related]  

  • 24. [Combined effect of reserpine and chlorpromazine in psychiatric practice].
    REDA GC; GERMANO V
    Arch Psicol Neurol Psichiatr; 1956; 17(2-3):647-53. PubMed ID: 13341438
    [No Abstract]   [Full Text] [Related]  

  • 25. An evaluation of the clinical significance of reserpine.
    TYHURST JS; RICHMAN A
    J Nerv Ment Dis; 1955 Nov; 122(5):492-5. PubMed ID: 13320149
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of parenterally administered reserpine.
    REA EL; FAZEKAS JF
    AMA Arch Intern Med; 1955 Apr; 95(4):538-9. PubMed ID: 14360827
    [No Abstract]   [Full Text] [Related]  

  • 27. [Proceedings of the Symposium on Reserpine and Chlorpromazine in Neuropsychiatry].
    Arch Psicol Neurol Psichiatr; 1956; 17(2-3):115-684. PubMed ID: 13341386
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapeutic effects of serpasil in a group of mental patients].
    SANTANGELO F
    Arch Psicol Neurol Psichiatr; 1956; 17(2-3):408-11. PubMed ID: 13341409
    [No Abstract]   [Full Text] [Related]  

  • 29. [Use of serpasil in neuropsychiatry].
    COIRAULT R; GIRARD V; BENOIT P
    Bull Mens Soc Med Mil Fr; 1955 Nov; 49(9):249-50. PubMed ID: 13304539
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of reserpine therapy on Funkenstein test reactions in maladapting patients.
    SHANKEL LW; WHITTIER JR
    Dis Nerv Syst; 1956 Aug; 17(8):258-61. PubMed ID: 13344336
    [No Abstract]   [Full Text] [Related]  

  • 31. [General considerations on the use of chlorpromazine and reserpine in the treatment of about three hundred mental patients].
    TRIPI G
    Arch Psicol Neurol Psichiatr; 1956; 17(2-3):635-9. PubMed ID: 13341435
    [No Abstract]   [Full Text] [Related]  

  • 32. The use of reserpine in an acute psychiatric treatment setting.
    TOURNEY G; ISBERG EM; GOTTLIEB JS
    AMA Arch Neurol Psychiatry; 1955 Sep; 74(3):325-8. PubMed ID: 13248291
    [No Abstract]   [Full Text] [Related]  

  • 33. Reserpine (serpasil) in the management of the mentally ill.
    NOCE RH; WILLIAMS DB; RAPAPORT W
    J Am Med Assoc; 1955 May; 158(1):11-5. PubMed ID: 14367027
    [No Abstract]   [Full Text] [Related]  

  • 34. A controlled study of reserpine on chronically disturbed patients.
    SOMMERNESS MD; LUCERO RJ; HAMLON JS; ERICKSON JL; MATTHEWS R
    AMA Arch Neurol Psychiatry; 1955 Sep; 74(3):316-9. PubMed ID: 13248289
    [No Abstract]   [Full Text] [Related]  

  • 35. CHLORPROMAZINE and reserpine; symposium on experiences at Saint Elizabeths Hospital.
    Med Ann Dist Columbia; 1956 May; 25(5):255-68; passim. PubMed ID: 13321175
    [No Abstract]   [Full Text] [Related]  

  • 36. [Medical and psychotherapeutic effect of serpasil].
    MIELKE FA
    Schweiz Med Wochenschr; 1956 Feb; 86(7):162-5. PubMed ID: 13311443
    [No Abstract]   [Full Text] [Related]  

  • 37. [Reflections on treatment by largactil and serpasil].
    RANCE AM; JURQUET A; ROGER J
    Ann Med Psychol (Paris); 1956 Jul; 114(2):320-7. PubMed ID: 13340398
    [No Abstract]   [Full Text] [Related]  

  • 38. Psychodynamic aspects of reserpine: its uses and effects in open psychiatric settings.
    SARWER-FONER GJ; OGLE W
    Can Psychiatr Assoc J; 1956 Jan; 1(1):11-7. PubMed ID: 13304728
    [No Abstract]   [Full Text] [Related]  

  • 39. Improved behavior patterns in the hospitalized mentally ill with reserpine and methyl-phenidylacetate.
    FERGUSON JT
    Psychiatr Res Rep Am Psychiatr Assoc; 1956 Apr; (4):35-43. PubMed ID: 13323110
    [No Abstract]   [Full Text] [Related]  

  • 40. Serpasil in a hospital for the mentally ill with criminal tendencies.
    MCNEILL JF; JOHNSTON WC; PIETUCHOW W
    N Y State J Med; 1956 Jun; 56(12):1911-4. PubMed ID: 13322283
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.